IL10 and colitis: Additionally, activating GPCR109A with SCFAs boosts anti‐inflammatory factor production, stimulates regulatory T‐cell activity, and fosters the development of IL‐10‐producing T cells, crucial for colitis prevention (Singh et al. 2014).